AbCellera and Merck Sign Novel Therapeutic Antibody Discovery Collaboration
27. Januar 2016 16:08 ET
|
AbCellera
VANCOUVER, British Columbia, Jan. 27, 2016 (GLOBE NEWSWIRE) -- AbCellera, a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells, today...
AbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola Virus
20. Januar 2016 19:13 ET
|
AbCellera
VANCOUVER, British Columbia, Jan. 20, 2016 (GLOBE NEWSWIRE) -- AbCellera announced today successful completion of its first antibody discovery partnership with MassBiologics of the University...